UK's Glaxo Smith Kline Aims to Market First Malaria Vaccine
October 8, 2013
Reuters / Powered by NewsLook.com
British drug maker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed it significantly cut cases of the disease in African children. As Joanna Partridge reports it will be welcome news for a UK company recently battered by a corruption scandal in China.
AFP (Apr. 24, 2014) World Malaria Day is commemorated every year on April 25 and recognizes global efforts to control malaria. Seasonal malaria chemoprevention is a new prevention strategy for Niger. Duration: ... watch video
AFP (Oct. 8, 2013) Experts in Africa, the continent worst-hit by malaria, reacted with optimism but also caution on Tuesday at hopes that the first vaccine against the killer disease may soon reach the market. ... watch video
Reuters - Innovations Video Online (May 2, 2016) An over the counter kit used to test for malaria at home using a patient's urine could make a substantial impact in the global fight to eliminate malaria by 2030.
Video provided by ... watch video
Reuters - News Video Online (Apr. 24, 2015) The world's first anti-malaria vaccine could get the go-ahead for use in Africa from October if approved by international regulators. Paul Chapman reports.
Video provided by ... watch video
AFP (July 24, 2015) The world's most advanced malaria vaccine got the nod Friday from European regulators, despite mixed trial results, for eventual use in children in African countries plagued by the killer ... watch video
Reuters (Aug. 5, 2013) Israeli drug company SciVac has developed a third-generation vaccine for Hepatitis B, a virus that kills more than half a million people each year. The company says the vaccine has the potential to ... watch video
July 28, 2016 Researchers have developed a hybrid treatment that harnesses a monoclonal antibody to deliver antisense DNA to acute lymphoblastic leukemia (ALL) cells and that may lead to less toxic treatments for ... read more
July 28, 2016 A protein discovery offers a possible test for ovarian cancer, report scientists. The research team also identified an enzyme vital to ovarian cancer growth and spread, offering a target for new ... read more
July 28, 2016 An international team of researchers has discovered the mutation responsible for a rare, newly identified genetic disorder that causes craniofacial abnormalities and developmental delays. The ... read more
July 28, 2016 Researchers have identified a new way to target lung cancer through the KRAS gene, one of the most commonly mutated genes in human cancer and one researchers have so far had ... read more
July 29, 2016 Patients carrying certain mutations that cause Long QT Syndrome, a rare cardiac rhythm disorder, have an increased risk for developing seizures and have more severe cardiac ... read more
Apr. 12, 2016 Although the World Health Organization decided not to recommend the use of RTS,S/AS01, the most advanced malaria vaccine candidate that is in development, in infants within the Expanded Programme of ... read more
Apr. 23, 2015 The first malaria vaccine candidate (RTS,S/AS01) to reach phase 3 clinical testing is partially effective against clinical disease in young African children up to 4 years after vaccination, according ... read more
July 29, 2014 A vaccine previously shown to reduce malaria in young infants and children reduces larger numbers of malaria cases in areas of higher malaria transmission, according to results from an ongoing ... read more
May 7, 2014 Although malaria kills some 600,000 African children each year, most cases of the mosquito-borne parasitic disease in children are mild. Repeated infection does generate some immunity, and episodes ... read more